查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790309

美国mRNA 合成原料市场规模、份额和趋势分析报告：按类型、应用、最终用途和细分市场预测，2025 年至 2033 年

U.S. mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

美国mRNA合成原料市场摘要

美国mRNA 合成原料市场规模预计在 2024 年为 5.41 亿美元，预计到 2033 年将达到 9.322 亿美元，2025 年至 2033 年的复合年增长率为 6.57%。推动这一增长的因素包括学术界和工业界对 mRNA 技术的兴趣日益浓厚、mRNA 研究资金增加以及人们对基于 mRNA 的疫苗益处的认识不断提高。

此外，预计 RNA 技术日益增长的治疗应用将在预测期内推动对 mRNA 合成原料的大量需求。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场问题分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析

第四章 类型业务分析

  • 类型细分仪表板
  • 美国mRNA合成原料市场波动分析
  • 美国mRNA 合成原料市场规模及趋势分析（2021-2033）
  • 封端剂
    • CleanCap 试剂
    • ARCA（防反接电容模拟）
    • 其他的
  • 核苷酸
    • 修饰核酸
    • 天然核酸
  • 质体DNA
  • 酵素
    • 聚合酵素
    • RNase抑制剂
    • DNase
    • 其他的
  • 其他的

第五章：应用业务分析

  • 应用程式细分仪表板
  • 美国mRNA合成原料市场使用趋势分析
  • 美国mRNA 合成原料市场规模及趋势分析（依应用，2021-2033）
  • 治疗药物製造
  • 疫苗生产
  • 其他用途

第六章 最终用途业务分析

  • 最终用途细分仪表板
  • 美国mRNA合成原料市场最终用途差异分析
  • 美国mRNA 合成原料市场规模及趋势分析（依最终用途，2021-2033 年）
  • 生物製药和製药公司
  • CRO 和 CMO
  • 学术研究机构

第七章 竞争态势

  • 公司分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • F. Hoffmann-La Roche Ltd.
    • Jena Bioscience GmbH
    • Merck KGaA
    • Yeasen Biotechnology（Shanghai）Co., Ltd
    • BOC Sciences
    • Thermo Fisher Scientific, Inc.
    • Maravai LifeSciences
    • New England Biolabs
    • Creative Biogene
    • HONGENE
    • Evonik Industries AG
    • GENEVANT SCIENCES CORPORATION
Product Code: GVR-4-68040-283-7

U.S. mRNA Synthesis Raw Materials Market Summary

The U.S. mRNA synthesis raw materials market size was estimated at USD 541.0 million in 2024 and is projected to reach USD 932.2 million by 2033, growing at a CAGR of 6.57% from 2025 to 2033. This growth is attributed to the growing academic & industrial interest in mRNA technology, increasing funding for mRNA research, and rising awareness of the advantages of mRNA-based vaccines.

Moreover, the increasing therapeutic applications of RNA technology are anticipated to provide significant demand for the mRNA synthesis raw materials over the forecast period.

U.S. mRNA Synthesis Raw Materials Market Report Segmentation

This report forecasts revenue growth in the U.S. and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. mRNA synthesis raw materials market report based on type, application, and end use:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Capping Agents
  • CleanCap Reagents
  • ARCA (Anti-Reverse Cap Analog)
  • Others
  • Nucleotides
  • Modified Nucleic Acids
    • N1-methylpseudouridine-triphosphate
    • 5-Methylcytidine triphosphate (5mCTP)
    • Others
  • Natural Nucleic Acids
    • Adenine
    • Guanine
    • Cytosine
    • Uracil
  • Plasmid DNA
  • Enzymes
  • Polymerase
  • RNase Inhibitor
  • DNase
  • Others
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Vaccine Production
  • Therapeutics Production
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Type Segment
    • 1.1.2. Application Segment
    • 1.1.3. End Use Segment
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Primary Research
  • 1.5. Information or Data Analysis:
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing academic & industrial interest in mRNA technology
      • 3.2.1.2. Advantages of mRNA vaccines
      • 3.2.1.3. Increasing funding for mRNA research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Nonexistence of effective government regulations for mRNA-based product approvals
      • 3.2.2.2. High cost of mRNA synthesis raw materials
    • 3.2.3. Market Challenge Analysis
      • 3.2.3.1. Lack of long-lasting and affordable manufacturing processes
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. U.S. mRNA Synthesis Raw Materials Market Type Movement Analysis
  • 4.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Capping Agents
    • 4.4.1. Capping agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. CleanCap Reagents
      • 4.4.2.1. CleanCap reagents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. ARCA (Anti-Reverse Cap Analog)
      • 4.4.3.1. ARCA (anti-reverse cap analog) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Nucleotides
    • 4.5.1. Nucleotides market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Modified Nucleic Acids
      • 4.5.2.1. Modified nucleic acids market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.2. N1-methylpseudouridine-triphosphate
        • 4.5.2.2.1. N1-methylpseudouridine-triphosphate market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.3. 5-Methylcytidine triphosphate (5mCTP)
        • 4.5.2.3.1. 5-Methylcytidine triphosphate (5mCTP) market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.4. Others
        • 4.5.2.4.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Natural Nucleic Acids
      • 4.5.3.1. Natural nucleic acids market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.2. Adenine
        • 4.5.3.2.1. Adenine market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.3. Guanine
        • 4.5.3.3.1. Guanine market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.4. Cytosine
        • 4.5.3.4.1. Cytosine market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.5. Uracil
        • 4.5.3.5.1. Uracil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Plasmid DNA
    • 4.6.1. Plasmid DNA market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Enzymes
    • 4.7.1. Enzymes market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Polymerase
      • 4.7.2.1. Polymerase market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. RNase Inhibitor
      • 4.7.3.1. RNase inhibitor market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. DNase
      • 4.7.4.1. DNase market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.5. Others
      • 4.7.5.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. mRNA Synthesis Raw Materials Market Application Movement Analysis
  • 5.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Therapeutics Production
    • 5.4.1. Therapeutics production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Vaccine Production
    • 5.5.1. Vaccine production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Other Application
    • 5.6.1. Other application market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. U.S. mRNA Synthesis Raw Materials Market End Use Movement Analysis
  • 6.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical & Pharmaceutical Companies
    • 6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. CROs & CMOs
    • 6.5.1. CROs & CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Academic & Research Institutes
    • 6.6.1. Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. F. Hoffmann-La Roche Ltd.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Jena Bioscience GmbH
      • 7.4.2.1. Overview
      • 7.4.2.2. Product Benchmarking
      • 7.4.2.3. Strategic Initiatives
    • 7.4.3. Merck KGaA
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Yeasen Biotechnology (Shanghai) Co., Ltd
      • 7.4.4.1. Overview
      • 7.4.4.2. Product Benchmarking
      • 7.4.4.3. Strategic Initiatives
    • 7.4.5. BOC Sciences
      • 7.4.5.1. Overview
      • 7.4.5.2. Product Benchmarking
      • 7.4.5.3. Strategic Initiatives
    • 7.4.6. Thermo Fisher Scientific, Inc.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Maravai LifeSciences
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. New England Biolabs
      • 7.4.8.1. Overview
      • 7.4.8.2. Product Benchmarking
      • 7.4.8.3. Strategic Initiatives
    • 7.4.9. Creative Biogene
      • 7.4.9.1. Overview
      • 7.4.9.2. Product Benchmarking
      • 7.4.9.3. Strategic Initiatives
    • 7.4.10. HONGENE
      • 7.4.10.1. Overview
      • 7.4.10.2. Product Benchmarking
      • 7.4.10.3. Strategic Initiatives
    • 7.4.11. Evonik Industries AG
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. GENEVANT SCIENCES CORPORATION
      • 7.4.12.1. Overview
      • 7.4.12.2. Product Benchmarking
      • 7.4.12.3. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. mRNA synthesis raw materials market, by type, 2021 - 2033 (USD Million)
  • Table 4 U.S. mRNA synthesis raw materials market, by application, 2021 - 2033 (USD Million)
  • Table 5 U.S. mRNA synthesis raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 6 Key companies undergoing expansions.
  • Table 7 Key companies undergoing acquisitions.
  • Table 8 Key companies undergoing collaborations.
  • Table 9 Key companies launching new products/services.
  • Table 10 Key companies undertaking other strategies.

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. mRNA synthesis raw materials market: market outlook
  • Fig. 7 U.S. mRNA synthesis raw materials competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 U.S. mRNA synthesis raw materials market driver impact
  • Fig. 10 U.S. mRNA synthesis raw materials market restraint impact: Type & services movement analysis
  • Fig. 11 U.S. mRNA synthesis raw materials market: Type outlook and key takeaways
  • Fig. 12 Capping agents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 13 CleanCap reagents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 14 ARCA (anti-reverse cap analog) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Nucleotides market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Modified nucleic acids market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 N1-methylpseudouridine-triphosphate market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 5-Methylcytidine triphosphate (5mCTP) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Natural nucleic acids market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 22 Adenine market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Guanine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Cytosine market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Uracil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Plasmid DNA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Enzymes market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Polymerase market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 RNase inhibitor market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 DNase materials market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Others market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 33 U.S. mRNA synthesis raw materials market: Application movement analysis
  • Fig. 34 U.S. mRNA synthesis raw materials market: Application outlook and key takeaways
  • Fig. 35 Vaccine production market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Therapeutics production market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Other application market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. mRNA synthesis raw materials market: End Use movement analysis
  • Fig. 39 U.S. mRNA synthesis raw materials market: End Use outlook and key takeaways
  • Fig. 40 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Biopharmaceutical & pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 CROs CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Market share of key market players - U.S. mRNA synthesis raw materials market